200 related articles for article (PubMed ID: 31097753)
21. 'Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin.
Abu-Tayeh H; Weidenfeld K; Zhilin-Roth A; Schif-Zuck S; Thaler S; Cotarelo C; Tan TZ; Thiery JP; Green JE; Klorin G; Sabo E; Sleeman JP; Tzukerman M; Barkan D
Cell Death Dis; 2016 Dec; 7(12):e2491. PubMed ID: 27906177
[TBL] [Abstract][Full Text] [Related]
22. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
23. Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy.
Nayak B; Balachander GM; Manjunath S; Rangarajan A; Chatterjee K
Colloids Surf B Biointerfaces; 2019 Aug; 180():334-343. PubMed ID: 31075687
[TBL] [Abstract][Full Text] [Related]
24. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip.
Zhang YS; Arneri A; Bersini S; Shin SR; Zhu K; Goli-Malekabadi Z; Aleman J; Colosi C; Busignani F; Dell'Erba V; Bishop C; Shupe T; Demarchi D; Moretti M; Rasponi M; Dokmeci MR; Atala A; Khademhosseini A
Biomaterials; 2016 Dec; 110():45-59. PubMed ID: 27710832
[TBL] [Abstract][Full Text] [Related]
25. Engineering innervated secretory epithelial organoids by magnetic three-dimensional bioprinting for stimulating epithelial growth in salivary glands.
Adine C; Ng KK; Rungarunlert S; Souza GR; Ferreira JN
Biomaterials; 2018 Oct; 180():52-66. PubMed ID: 30025245
[TBL] [Abstract][Full Text] [Related]
26. [Normal organoids and their applications in cancer research].
Delom F; Le Morvan V; Robert J; Fessart D
Bull Cancer; 2022 Jan; 109(1):58-64. PubMed ID: 34903368
[TBL] [Abstract][Full Text] [Related]
27. A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses.
Raffo-Romero A; Ziane-Chaouche L; Salomé-Desnoulez S; Hajjaji N; Fournier I; Salzet M; Duhamel M
Cell Rep Methods; 2024 Jun; 4(6):100792. PubMed ID: 38861990
[TBL] [Abstract][Full Text] [Related]
28. 3D Bioprinting and Stem Cells.
Moore CA; Shah NN; Smith CP; Rameshwar P
Methods Mol Biol; 2018; 1842():93-103. PubMed ID: 30196404
[TBL] [Abstract][Full Text] [Related]
29. The potential application of organoids in breast cancer research and treatment.
Ebrahimi N; Nasr Esfahani A; Samizade S; Mansouri A; Ghanaatian M; Adelian S; Shadman Manesh V; Hamblin MR
Hum Genet; 2022 Feb; 141(2):193-208. PubMed ID: 34713317
[TBL] [Abstract][Full Text] [Related]
30. Current Status of Breast Organoid Models.
Mohan SC; Lee TY; Giuliano AE; Cui X
Front Bioeng Biotechnol; 2021; 9():745943. PubMed ID: 34805107
[TBL] [Abstract][Full Text] [Related]
31. Derivation of a robust mouse mammary organoid system for studying tissue dynamics.
Jamieson PR; Dekkers JF; Rios AC; Fu NY; Lindeman GJ; Visvader JE
Development; 2017 Mar; 144(6):1065-1071. PubMed ID: 27993977
[TBL] [Abstract][Full Text] [Related]
32. A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer.
Djomehri SI; Burman B; Gonzalez ME; Takayama S; Kleer CG
J Cell Commun Signal; 2019 Mar; 13(1):129-143. PubMed ID: 30515709
[TBL] [Abstract][Full Text] [Related]
33. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.
Kalla J; Pfneissl J; Mair T; Tran L; Egger G
Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38806997
[TBL] [Abstract][Full Text] [Related]
34. Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture.
Briem E; Ingthorsson S; Traustadottir GA; Hilmarsdottir B; Gudjonsson T
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):139-147. PubMed ID: 30684066
[TBL] [Abstract][Full Text] [Related]
35. Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.
Lebret SC; Newgreen DF; Waltham MC; Price JT; Thompson EW; Ackland ML
In Vitro Cell Dev Biol Anim; 2006; 42(10):298-307. PubMed ID: 17316063
[TBL] [Abstract][Full Text] [Related]
36. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
[TBL] [Abstract][Full Text] [Related]
37. Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer.
Roelofs C; Hollande F; Redvers R; Anderson RL; Merino D
Biochem Soc Trans; 2019 Feb; 47(1):109-117. PubMed ID: 30626705
[TBL] [Abstract][Full Text] [Related]
38. Functional purification of human and mouse mammary stem cells.
Tosoni D; Di Fiore PP; Pece S
Methods Mol Biol; 2012; 916():59-79. PubMed ID: 22914933
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo translational models for rare liver diseases.
Haugabook SJ; Ferrer M; Ottinger EA
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):1003-1018. PubMed ID: 30075192
[TBL] [Abstract][Full Text] [Related]
40. Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions.
Yue X; Nguyen TD; Zellmer V; Zhang S; Zorlutuna P
Biomaterials; 2018 Jul; 170():37-48. PubMed ID: 29653286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
